South Korea's ADEL signs up to $1.04 billion Alzheimer's drug development deal with Sanofi - Reuters

Reuters | Dec. 15, 2025, 6:59 p.m. | Original
South Korea's ADEL signs up to $1.04 billion Alzheimer's drug development deal with Sanofi Reuters
Australia's Star Entertainment CEO Steve McCann exits with immediate effect - Reuters Exclusive: Britain examines revamp of capital rules for likes of Citadel and XTX - Reuters